{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T05:45:07Z","timestamp":1784007907102,"version":"3.55.0"},"reference-count":73,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003180","name":"Amsterdam UMC - Locatie AMC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003180","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002996","name":"Hartstichting","doi-asserted-by":"publisher","award":["03-003-2021-T061"],"award-info":[{"award-number":["03-003-2021-T061"]}],"id":[{"id":"10.13039\/501100002996","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002996","name":"Hartstichting","doi-asserted-by":"publisher","award":["2018-30 PREDICT2"],"award-info":[{"award-number":["2018-30 PREDICT2"]}],"id":[{"id":"10.13039\/501100002996","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002996","name":"Hartstichting","doi-asserted-by":"publisher","award":["ZonMW 40\u201346300\u201398\u201319009"],"award-info":[{"award-number":["ZonMW 40\u201346300\u201398\u201319009"]}],"id":[{"id":"10.13039\/501100002996","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cardiacep.theclinics.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiac Electrophysiology Clinics"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.ccep.2023.05.002","type":"journal-article","created":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T09:42:47Z","timestamp":1687254167000},"page":"273-283","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Novelties in Brugada Syndrome: Complex Genetics, Risk Stratification, and Catheter Ablation"],"prefix":"10.1016","volume":"15","author":[{"given":"Wiert F.","family":"Hoeksema","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad S.","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connie R.","family":"Bezzina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur A.M.","family":"Wilde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter G.","family":"Postema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ccep.2023.05.002_bib1","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/00000441-195322650-00011","article-title":"Electrocardiographic pattern simulating acute myocardial injury","volume":"226","author":"Osher","year":"1953","journal-title":"Am J Med Sci"},{"issue":"6","key":"10.1016\/j.ccep.2023.05.002_bib2","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/0002-8703(89)90011-2","article-title":"Ventricular fibrillation without apparent heart disease: description of six cases","volume":"118","author":"Martini","year":"1989","journal-title":"Am Heart J"},{"issue":"6","key":"10.1016\/j.ccep.2023.05.002_bib3","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/0735-1097(92)90253-J","article-title":"Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report","volume":"20","author":"Brugada","year":"1992","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"40","key":"10.1016\/j.ccep.2023.05.002_bib4","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","volume":"43","author":"Zeppenfeld","year":"2022","journal-title":"Eur Heart J"},{"issue":"19","key":"10.1016\/j.ccep.2023.05.002_bib5","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1161\/01.CIR.0000034169.45752.4A","article-title":"Proposed diagnostic criteria for the Brugada syndrome: consensus report","volume":"106","author":"Wilde","year":"2002","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ccep.2023.05.002_bib6","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1161\/01.CIR.0000152479.54298.51","article-title":"Brugada syndrome: report of the second consensus conference: endorsed by the heart rhythm society and the European heart rhythm association","volume":"111","author":"Antzelevitch","year":"2005","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.ccep.2023.05.002_bib7","doi-asserted-by":"crossref","first-page":"e295","DOI":"10.1016\/j.hrthm.2016.05.024","article-title":"J-Wave syndromes expert consensus conference report: emerging concepts and gaps in knowledge","volume":"13","author":"Antzelevitch","year":"2016","journal-title":"Heart Rhythm"},{"issue":"7","key":"10.1016\/j.ccep.2023.05.002_bib8","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1093\/europace\/eus042","article-title":"About Brugada syndrome and its prevalence","volume":"14","author":"Postema","year":"2012","journal-title":"EP Europace"},{"issue":"3","key":"10.1016\/j.ccep.2023.05.002_bib9","first-page":"267","article-title":"Worldwide prevalence of brugada syndrome: a systematic review and meta-analysis","volume":"34","author":"Vutthikraivit","year":"2018","journal-title":"Acta Cardiol Sin"},{"issue":"4","key":"10.1016\/j.ccep.2023.05.002_bib10","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/j.1540-8167.2006.00759.x","article-title":"Gender differences in Brugada syndrome","volume":"18","author":"Eckardt","year":"2007","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"issue":"13","key":"10.1016\/j.ccep.2023.05.002_bib11","first-page":"e210","volume":"138","author":"Al-Khatib","year":"2018","journal-title":"Circulation"},{"issue":"16","key":"10.1016\/j.ccep.2023.05.002_bib12","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1161\/CIRCULATIONAHA.113.001941","article-title":"Outcome after implantation of a cardioverter-defibrillator in patients with brugada syndrome","volume":"128","author":"Sacher","year":"2013","journal-title":"Circulation"},{"issue":"6673","key":"10.1016\/j.ccep.2023.05.002_bib13","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/32675","article-title":"Genetic basis and molecular mechanism for idiopathic ventricular fibrillation","volume":"392","author":"Chen","year":"1998","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.ccep.2023.05.002_bib14","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0008-6363(99)00350-8","article-title":"Human SCN5A gene mutations alter cardiac sodium channel kinetics and are associated with the Brugada syndrome","volume":"44","author":"Rook","year":"1999","journal-title":"Cardiovasc Res"},{"issue":"20","key":"10.1016\/j.ccep.2023.05.002_bib15","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1161\/01.CIR.102.20.2509","article-title":"Clinical and genetic heterogeneity of right bundle branch block and ST-segment elevation syndrome","volume":"102","author":"Priori","year":"2000","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.ccep.2023.05.002_bib16","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1161\/CIRCGENETICS.109.853374","article-title":"SCN5A mutations and the role of genetic background in the pathophysiology of Brugada syndrome","volume":"2","author":"Probst","year":"2009","journal-title":"Circ Cardiovasc Genet"},{"issue":"3","key":"10.1016\/j.ccep.2023.05.002_bib17","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.tcm.2008.01.002","article-title":"Cardiac sodium channel overlap syndromes: different faces of SCN5A mutations","volume":"18","author":"Remme","year":"2008","journal-title":"Trends Cardiovasc Med"},{"issue":"5","key":"10.1016\/j.ccep.2023.05.002_bib18","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.jacep.2018.03.006","article-title":"Clinical spectrum of SCN5A mutations: long QT Syndrome, Brugada syndrome, and cardiomyopathy","volume":"4","author":"Wilde","year":"2018","journal-title":"JACC Clin Electrophysiol"},{"issue":"7","key":"10.1016\/j.ccep.2023.05.002_bib19","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1161\/CIRCULATIONAHA.118.035954","article-title":"Beyond the one gene\u2013one disease paradigm","volume":"140","author":"Cerrone","year":"2019","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.ccep.2023.05.002_bib20","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1161\/CIRCULATIONAHA.118.035070","article-title":"Reappraisal of reported genes for sudden arrhythmic death","volume":"138","author":"Hosseini","year":"2018","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ccep.2023.05.002_bib21","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.hrthm.2009.09.069","article-title":"An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing","volume":"7","author":"Kapplinger","year":"2010","journal-title":"Heart Rhythm"},{"issue":"2","key":"10.1016\/j.ccep.2023.05.002_bib22","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/nrg3118","article-title":"Rare and common variants: twenty arguments","volume":"13","author":"Gibson","year":"2012","journal-title":"Nat Rev Genet"},{"issue":"9","key":"10.1016\/j.ccep.2023.05.002_bib23","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1038\/ng.2712","article-title":"Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death","volume":"45","author":"Bezzina","year":"2013","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.ccep.2023.05.002_bib24","first-page":"e002797","article-title":"Validation and disease risk assessment of previously reported genome-wide genetic variants associated with brugada syndrome","volume":"13","author":"Juang","year":"2020","journal-title":"Circulation: Genomic and Precision Medicine"},{"issue":"37","key":"10.1016\/j.ccep.2023.05.002_bib25","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1093\/eurheartj\/ehz435","article-title":"Predicting cardiac electrical response to sodium-channel blockade and Brugada syndrome using polygenic risk scores","volume":"40","author":"Tadros","year":"2019","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.ccep.2023.05.002_bib26","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/s41588-021-01007-6","article-title":"Genome-wide association analyses identify new Brugada syndrome risk loci and highlight a new mechanism of sodium channel regulation in disease susceptibility","volume":"54","author":"Barc","year":"2022","journal-title":"Nat Genet"},{"issue":"7","key":"10.1016\/j.ccep.2023.05.002_bib27","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.hrthm.2022.03.1225","article-title":"European heart rhythm association (EHRA)\/Heart rhythm society (HRS)\/Asia pacific heart rhythm society (APHRS)\/Latin American heart rhythm society (LAHRS) expert consensus statement on the state of genetic testing for cardiac diseases","volume":"19","author":"Wilde","year":"2022","journal-title":"Heart Rhythm"},{"issue":"4","key":"10.1016\/j.ccep.2023.05.002_bib28","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.yjmcc.2010.07.012","article-title":"The pathophysiological mechanism underlying Brugada syndrome: depolarization versus repolarization","volume":"49","author":"Wilde","year":"2010","journal-title":"J\u00a0Mol Cell Cardiol"},{"issue":"15","key":"10.1016\/j.ccep.2023.05.002_bib29","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1161\/01.CIR.100.15.1660","article-title":"Cellular basis for the brugada syndrome and other mechanisms of arrhythmogenesis associated with ST-segment elevation","volume":"100","author":"Yan","year":"1999","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ccep.2023.05.002_bib30","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.cardiores.2005.03.005","article-title":"Pathophysiological mechanisms of Brugada syndrome: depolarization disorder, repolarization disorder, or more?","volume":"67","author":"Meregalli","year":"2005","journal-title":"Cardiovasc Res"},{"issue":"3","key":"10.1016\/j.ccep.2023.05.002_bib31","first-page":"283","article-title":"The brugada ECG pattern","volume":"3","author":"Hoogendijk","year":"2010","journal-title":"Circulation: Arrhythmia and Electrophysiology"},{"issue":"18","key":"10.1016\/j.ccep.2023.05.002_bib32","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1016\/j.jacc.2015.08.862","article-title":"Fibrosis, connexin-43, and conduction abnormalities in the brugada syndrome","volume":"66","author":"Nademanee","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.ccep.2023.05.002_bib33","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1093\/ejechocard\/jer139","article-title":"Altered two-dimensional strain measures of the right ventricle in patients with Brugada syndrome and arrhythmogenic right ventricular dysplasia\/cardiomyopathy","volume":"12","author":"Iacoviello","year":"2011","journal-title":"Eur J Echocardiogr"},{"issue":"4","key":"10.1016\/j.ccep.2023.05.002_bib34","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.hrthm.2016.12.004","article-title":"Late gadolinium enhancement in Brugada syndrome: a marker for subtle underlying cardiomyopathy?","volume":"14","author":"Bastiaenen","year":"2017","journal-title":"Heart Rhythm"},{"issue":"1","key":"10.1016\/j.ccep.2023.05.002_bib35","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1536\/ihj.51.17","article-title":"Right ventricular histological substrate and conduction delay in patients with brugada syndrome","volume":"51","author":"Ohkubo","year":"2010","journal-title":"Int Heart J"},{"issue":"4","key":"10.1016\/j.ccep.2023.05.002_bib36","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.3390\/ijms22041570","article-title":"Fibrosis and conduction abnormalities as basis for overlap of brugada syndrome and early repolarization syndrome","volume":"22","author":"Boukens","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"11","key":"10.1016\/j.ccep.2023.05.002_bib37","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/eurheartj\/ehaa1051","article-title":"Brugada syndrome and reduced right ventricular outflow tract conduction reserve: a final common pathway?","volume":"42","author":"Behr","year":"2021","journal-title":"Eur Heart J"},{"issue":"12","key":"10.1016\/j.ccep.2023.05.002_bib38","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.hrthm.2013.05.014","article-title":"HRS\/EHRA\/APHRS Expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: <em>Document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013.<\/em>","volume":"10","author":"Priori","year":"2013","journal-title":"Heart Rhythm"},{"issue":"5","key":"10.1016\/j.ccep.2023.05.002_bib39","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1161\/01.CIR.101.5.510","article-title":"Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts","volume":"101","author":"Brugada","year":"2000","journal-title":"Circulation"},{"issue":"23","key":"10.1016\/j.ccep.2023.05.002_bib40","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1136\/hrt.2010.201244","article-title":"Utility of high and standard right precordial leads during ajmaline testing for the diagnosis of Brugada syndrome","volume":"96","author":"Govindan","year":"2010","journal-title":"Heart"},{"issue":"7","key":"10.1016\/j.ccep.2023.05.002_bib41","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/j.hrthm.2015.04.017","article-title":"Everybody has Brugada syndrome until proven otherwise?","volume":"12","author":"Viskin","year":"2015","journal-title":"Heart Rhythm"},{"issue":"12","key":"10.1016\/j.ccep.2023.05.002_bib42","first-page":"1400","article-title":"Yield and pitfalls of ajmaline testing in the evaluation of unexplained cardiac arrest and sudden unexplained death: single-center experience with 482 families","volume":"3","author":"Tadros","year":"2017","journal-title":"JACC (J Am Coll Cardiol): Clinical Electrophysiology"},{"issue":"12","key":"10.1016\/j.ccep.2023.05.002_bib43","first-page":"1409","article-title":"Read my lips: a positive ajmaline test does not always mean you have brugada syndrome","volume":"3","author":"Viskin","year":"2017","journal-title":"JACC (J Am Coll Cardiol): Clinical Electrophysiology"},{"issue":"7","key":"10.1016\/j.ccep.2023.05.002_bib44","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/j.hrthm.2015.03.015","article-title":"High prevalence of concealed Brugada syndrome in patients with atrioventricular nodal reentrant tachycardia","volume":"12","author":"Hasdemir","year":"2015","journal-title":"Heart Rhythm"},{"issue":"9","key":"10.1016\/j.ccep.2023.05.002_bib45","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1111\/pace.13414","article-title":"Coexistence of atrioventricular accessory pathways and drug-induced type 1 Brugada pattern","volume":"41","author":"Hasdemir","year":"2018","journal-title":"Pacing Clin Electrophysiol"},{"issue":"5","key":"10.1016\/j.ccep.2023.05.002_bib46","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1161\/CIRCULATIONAHA.109.887026","article-title":"Long-term prognosis of patients diagnosed with brugada syndrome","volume":"121","author":"Probst","year":"2010","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ccep.2023.05.002_bib47","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jacc.2015.10.020","article-title":"A\u00a0tale of 2 diseases: the history of long-QT syndrome and brugada syndrome","volume":"67","author":"Havakuk","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.ccep.2023.05.002_bib48","first-page":"724","article-title":"Shanghai Score system for diagnosis of brugada syndrome: validation of the score system and system and reclassification of the patients","volume":"4","author":"Kawada","year":"2018","journal-title":"JACC (J Am Coll Cardiol): Clinical Electrophysiology"},{"issue":"17","key":"10.1016\/j.ccep.2023.05.002_bib49","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1093\/eurheartj\/ehaa1100","article-title":"Risk stratification in Brugada syndrome: the challenge of the grey zone","volume":"42","author":"Delise","year":"2021","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.ccep.2023.05.002_bib50","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jacep.2020.08.032","article-title":"A\u00a0primary prevention clinical risk score model for patients with brugada syndrome (BRUGADA-RISK)","volume":"7","author":"Honarbakhsh","year":"2021","journal-title":"JACC Clin Electrophysiol"},{"issue":"10","key":"10.1016\/j.ccep.2023.05.002_bib51","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.hrthm.2017.04.044","article-title":"Long-term prognosis of drug-induced Brugada syndrome","volume":"14","author":"Sieira","year":"2017","journal-title":"Heart Rhythm"},{"issue":"22","key":"10.1016\/j.ccep.2023.05.002_bib52","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1093\/eurheartj\/ehx119","article-title":"A\u00a0score model to predict risk of events in patients with Brugada Syndrome","volume":"38","author":"Sieira","year":"2017","journal-title":"Eur Heart J"},{"issue":"17","key":"10.1016\/j.ccep.2023.05.002_bib53","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1093\/eurheartj\/ehaa763","article-title":"Robustness and relevance of predictive score in sudden cardiac death for patients with Brugada syndrome","volume":"42","author":"Probst","year":"2021","journal-title":"Eur Heart J"},{"issue":"9","key":"10.1016\/j.ccep.2023.05.002_bib54","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.hrthm.2009.07.002","article-title":"Drugs and brugada syndrome patients: review of the literature, recommendations, and an up-to-date website","volume":"6","author":"Postema","year":"2009","journal-title":"Heart Rhythm"},{"issue":"5","key":"10.1016\/j.ccep.2023.05.002_bib55","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.hroo.2020.10.002","article-title":"Evaluation of subcutaneous implantable cardioverter-defibrillator performance in patients with ion channelopathies from the EFFORTLESS cohort and comparison with a meta-analysis of transvenous ICD outcomes","volume":"1","author":"Lambiase","year":"2020","journal-title":"Heart Rhythm O2"},{"issue":"6","key":"10.1016\/j.ccep.2023.05.002_bib56","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.jacc.2016.05.058","article-title":"Brugada syndrome and the subcutaneous implantable cardioverter-defibrillator","volume":"68","author":"Nordkamp","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccep.2023.05.002_bib57","article-title":"Lights and shadows of subcutaneous implantable cardioverter-defibrillator in Brugada syndrome","author":"Dendramis","year":"2022","journal-title":"Heart Rhythm"},{"issue":"1","key":"10.1016\/j.ccep.2023.05.002_bib58","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.hrthm.2010.09.066","article-title":"ST segment elevation by current-to-load mismatch: an experimental and computational study","volume":"8","author":"Hoogendijk","year":"2011","journal-title":"Heart Rhythm"},{"issue":"13","key":"10.1016\/j.ccep.2023.05.002_bib59","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1161\/01.CIR.0000143159.30585.90","article-title":"Efficacy of quinidine in high-risk patients with brugada syndrome","volume":"110","author":"Belhassen","year":"2004","journal-title":"Circulation"},{"issue":"13","key":"10.1016\/j.ccep.2023.05.002_bib60","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/j.jacc.2016.01.042","article-title":"Shock reduction with long-term quinidine in patients with brugada syndrome and malignant ventricular arrhythmia episodes","volume":"67","author":"Anguera","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.ccep.2023.05.002_bib61","first-page":"1393","article-title":"Management of brugada syndrome","volume":"8","author":"Belhassen","year":"2015","journal-title":"Circulation: Arrhythmia and Electrophysiology"},{"issue":"8","key":"10.1016\/j.ccep.2023.05.002_bib62","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.hrthm.2017.04.019","article-title":"The QUIDAM study: hydroquinidine therapy for the management of Brugada syndrome patients at high arrhythmic risk","volume":"14","author":"Andorin","year":"2017","journal-title":"Heart Rhythm"},{"issue":"5","key":"10.1016\/j.ccep.2023.05.002_bib63","first-page":"e007143","article-title":"Efficacy and limitations of quinidine in patients with brugada syndrome","volume":"12","author":"Mazzanti","year":"2019","journal-title":"Circulation: Arrhythmia and Electrophysiology"},{"issue":"12","key":"10.1016\/j.ccep.2023.05.002_bib64","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1093\/europace\/eum181","article-title":"Quinidine: a valuable medication joins the list of \u2018endangered species\u2019","volume":"9","author":"Viskin","year":"2007","journal-title":"EP Europace"},{"issue":"23","key":"10.1016\/j.ccep.2023.05.002_bib65","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1016\/j.jacc.2013.02.077","article-title":"Quinidine, a life-saving medication for brugada syndrome, is inaccessible in many countries","volume":"61","author":"Viskin","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"41","key":"10.1016\/j.ccep.2023.05.002_bib66","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1093\/eurheartj\/ehv316","volume":"36","author":"Priori","year":"2015","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.ccep.2023.05.002_bib67","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1161\/CIRCEP.115.003109","article-title":"Management of brugada syndrome: thirty-three-year experience using electrophysiologically guided therapy with class 1A antiarrhythmic drugs","volume":"8","author":"Belhassen","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"8","key":"10.1016\/j.ccep.2023.05.002_bib68","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1161\/01.CIR.0000088781.99943.95","article-title":"Mapping and ablation of ventricular fibrillation associated with long-QT and brugada syndromes","volume":"108","author":"Ha\u00efssaguerre","year":"2003","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.ccep.2023.05.002_bib69","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1161\/CIRCULATIONAHA.110.972612","article-title":"Prevention of ventricular fibrillation episodes in Brugada syndrome by catheter ablation over the anterior right ventricular outflow tract epicardium","volume":"123","author":"Nademanee","year":"2011","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ccep.2023.05.002_bib70","first-page":"e005053","article-title":"Electrical substrate elimination in 135 consecutive patients with brugada syndrome","volume":"10","author":"Pappone","year":"2017","journal-title":"Circulation: Arrhythmia and Electrophysiology"},{"issue":"18","key":"10.1016\/j.ccep.2023.05.002_bib71","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1161\/CIRCULATIONAHA.117.032624","article-title":"Radiofrequency ablation of asymptomatic brugada syndrome","volume":"137","author":"Viskin","year":"2018","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ccep.2023.05.002_bib72","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.hrthm.2012.12.013","article-title":"Epicardial ablation of ventricular tachycardia: an institutional experience of safety and efficacy","volume":"10","author":"Tung","year":"2013","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.ccep.2023.05.002_bib73","unstructured":"Nademanee K. Ablation in Brugada Syndrome for the Prevention of VF (BRAVE). Updated April 22, 2022. Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02704416. Accessed December 5, 2022."}],"container-title":["Cardiac Electrophysiology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877918223000497?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877918223000497?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T05:43:06Z","timestamp":1761802986000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877918223000497"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":73,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S1877918223000497"],"URL":"https:\/\/doi.org\/10.1016\/j.ccep.2023.05.002","relation":{},"ISSN":["1877-9182"],"issn-type":[{"value":"1877-9182","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novelties in Brugada Syndrome: Complex Genetics, Risk Stratification, and Catheter Ablation","name":"articletitle","label":"Article Title"},{"value":"Cardiac Electrophysiology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccep.2023.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}